Literature DB >> 11422750

Vascular function of the peripheral circulation in patients with nephrosis.

G F Watts1, S Herrmann, G K Dogra, D A Playford, J D Best, M A Thomas, A Irish.   

Abstract

BACKGROUND: Nephrotic syndrome is associated with abnormal lipoprotein metabolism and increased risk of coronary heart disease. Endothelial dysfunction, an early phase of atherogenesis that manifests as impaired flow-mediated dilation (FMD) of the peripheral circulation, may link these associations.
METHODS: We examined endothelial function of the brachial artery and forearm resistance arteries in 15 patients with nephrosis (NP), 15 patients with primary hyperlipidemia (HL) alone, and 15 normolipidemic, nonproteinuric subjects (NC) matched for age, sex, and weight. The NP and HL groups had similar serum cholesterol and triglyceride concentrations. Post-ischemic FMD (endothelium-dependent) and glyceryl trinitrate-mediated dilation (GTNMD; endothelium-independent) of the brachial artery were studied using ultrasonography and computerized edge detection software. Postischemic forearm blood flow was also measured using plethysmography.
RESULTS: Postischemic FMD of the brachial artery was significantly lower in the NP and HL groups compared with NC group (mean +/- SE): NP 4.91 +/- 0.8%, HL 4.53 +/- 0.6%, NC 8.45 +/- 0.5% (P < 0.001). There were no significant differences among the groups in baseline diameter and GTNMD of the brachial artery, nor in maximal forearm blood flow and flow debt repayment of the forearm microcirculation. Significant differences in FMD among the groups were principally related to differences in serum low-density lipoprotein cholesterol.
CONCLUSIONS: Patients with NP have abnormal endothelium-dependent but preserved endothelium-independent dilation of the brachial artery following an ischemic stimulus. Postischemic forearm microcirculatory function is unimpaired. Dyslipoproteinemia is probably the principal cause of endothelial dysfunction of conduit arteries in patients with NP and the basis for their increased risk of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422750     DOI: 10.1046/j.1523-1755.2001.00785.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome.

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Jolanta Tobolczyk; Edyta Tenderenda
Journal:  Pediatr Nephrol       Date:  2006-11-18       Impact factor: 3.714

2.  Brachial artery flow-mediated dilatation and carotid intima medial thickness in pediatric nephrotic syndrome: a cross-sectional case-control study.

Authors:  Illaparambath Rahul; Sriram Krishnamurthy; Santhosh Satheesh; Niranjan Biswal; Zachariah Bobby; Subitha Lakshminarayanan
Journal:  Clin Exp Nephrol       Date:  2014-03-18       Impact factor: 2.801

3.  Diminished macrophage cholesterol removal rate by the altered HDL metabolism in the Nagase analbuminemic rat.

Authors:  Sergio Catanozi; Jussara C Rocha; Marisa Passarelli; Carlos H Mesquita; Vivian Y Suguiama; Maria L Guzzo; Antônio dos Santos Filho; Eder C R Quintão; Edna R Nakandakare
Journal:  Lipids       Date:  2006-07       Impact factor: 1.880

Review 4.  Bone Health in Glomerular Kidney Disease.

Authors:  Dorey A Glenn; Michelle R Denburg
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

Review 5.  Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.

Authors:  Seiji Ueda; Sho-Ichi Yamagishi; Yuriko Matsumoto; Kei Fukami; Seiya Okuda
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

6.  Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease.

Authors:  Juliane Obermeier; Phillip Trefz; Josephine Happ; Jochen K Schubert; Hagen Staude; Dagmar-Christiane Fischer; Wolfram Miekisch
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

7.  Albumin is an interface between blood plasma and cell membrane, and not just a sponge.

Authors:  Jens van de Wouw; Jaap A Joles
Journal:  Clin Kidney J       Date:  2021-10-05

8.  Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease.

Authors:  Fan-Chi Chang; Tai-Shuan Lai; Chih-Kang Chiang; Yung-Ming Chen; Ming-Shiou Wu; Tzong-Shinn Chu; Kwan-Dun Wu; Shuei-Liong Lin
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

9.  Cardiovascular outcomes of Nephrotic syndrome in childhood (CVONS) study: a protocol for prospective cohort study.

Authors:  S K Patnaik; P Kumar; M Bamal; S Patel; M P Yadav; V Kumar; A Sinha; A Bagga; M Kanitkar
Journal:  BMC Nephrol       Date:  2018-04-03       Impact factor: 2.388

10.  Calcitriol Prevents Cardiovascular Repercussions in Puromycin Aminonucleoside-Induced Nephrotic Syndrome.

Authors:  Fernandes-Cerqueira Cátia; Quelhas-Santos Janete; Sampaio-Maia Benedita; Simões-Silva Liliana; Soares-Silva Isabel; Roncon-Albuquerque Roberto; Pestana Manuel
Journal:  Biomed Res Int       Date:  2018-01-23       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.